The Translational and Molecular Imaging Institute (TMII) is a comprehensive, multi-disciplinary, and integrated imaging research institute, which focuses on the use of multimodality imaging for brain, heart, and cancer research, along with research in nanomedicine for precision imaging and drug delivery. TMII is composed of research groups in all aspects of imaging research, including engineering, physics, chemistry, analysis, basic science, and medicine.
Our mission is centered around development, validation, translation and education of innovative technology in biomedical imaging to address both basic and clinical research problems and therefore improve human health.
Since 2013, the Translational and Molecular Imaging Institute occupies approximately 20,000 square feet at The Mount Sinai Medical Center. Housed on four partial floors (CSM-SC2, CSM-SC1, CSM-1, and CSM-7) of Mount Sinai’s new signature building, the Leon and Norma Hess Center for Science and Medicine, TMII is located in close proximity to both research and clinical activities in The Mount Sinai Medical Center. Space within the new facility was strategically designed to be flexible; it was built for today’s leading-edge research equipment, but it will also accommodate the evolution of research platforms as new technologies emerge in the future.
To fulfill our mission, TMII combines state-of-the-art facilities with outstanding faculty, technical staff scientists, and administrative support staff.
The Translational and Molecular Imaging Institute serves as a research catalyst for a new generation of translational and molecular imaging methodologies. TMII applies and validates imaging modalities, in both preclinical basic science and clinical research settings, to: